ALISertib in Patients with Extensive-Stage Small-Cell Lung Cancer: The Phase 2 ALISCA-Lung1 Study

被引：0

作者：

Owonikoko, T. ^{[1
]}

Burns, T. F. ^{[2
]}

Chiappori, A. A. ^{[3
]}

Drapkin, B. ^{[4
]}

Gentzler, R. D. ^{[5
]}

Goldschmidt, J. ^{[6
]}

Hakimian, D. ^{[7
]}

Jotte, R. ^{[8
]}

Liu, S. V. ^{[9
]}

Onitilo, A. A. ^{[10
]}

Pennell, N. A. ^{[11
]}

Potugari, B. ^{[12
]}

Rios, J. ^{[13
]}

Sands, J. ^{[14
]}

Spira, A. ^{[15
]}

Wang, B. ^{[16
]}

Waterhouse, D. M. ^{[17
]}

Lowenthal, B. ^{[18
]}

Bebchuk, J. ^{[18
]}

Eli, L. D. ^{[18
]}

Wong, E. K. ^{[18
]}

Dowlati, A. ^{[19
]}

机构：

[1] Univ Maryland, Baltimore, MD USA

[2] UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[4] Univ Texas SouthWestern Med Ctr, Dallas, TX USA

[5] Univ Virginia, Charlottesville, VA USA

[6] US Oncol, Blue Ridge Canc Ctr, Blacksburg, VA USA

[7] US Oncol, Illinois Canc Specialists, Niles, IL USA

[8] Rocky Mt Canc Ctr, Lone Tree, CO USA

[9] Georgetown Univ, Washington, DC USA

[10] Marshfield Clin Wisconsin, Rapids, WI USA

[11] Cleveland Clin, Cleveland, OH USA

[12] Henry Ford Hosp, Detroit, MI USA

[13] Sarah Cannon Zangmeister Canc Ctr Columbus, Columbus, OH USA

[14] Dana Faber Canc Inst, Boston, MA USA

[15] Virginia Canc Specialists Res Inst, Fairfax, VA USA

[16] Willamette Valley Canc Inst & Res Ctr, Eugene, OR USA

[17] OHC Oncol Hematol Care, Cincinnati, OH USA

[18] Puma Biotechnol, Los Angeles, CA USA

[19] Univ Hosp Cleveland Med Ctr, Cleveland, OH USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期

关键词：

Alisertib; Small-cell lung cancer; Aurora kinase A inhibitor;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.13A.13

引用

页码：S212 / S213

页数：2

共 50 条

[1] Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer
Nogami, Naoyuki
Tokito, Takaaki
Zenke, Yoshitaka
Satouchi, Miyako
Seto, Takashi
Saka, Hideo
Ohtani, Junko
Han, Shirong
Noguchi, Kazuo
Nishio, Makoto
INVESTIGATIONAL NEW DRUGS, 2024, 42 (01) : 136 - 144
[2] Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer
Naoyuki Nogami
Takaaki Tokito
Yoshitaka Zenke
Miyako Satouchi
Takashi Seto
Hideo Saka
Junko Ohtani
Shirong Han
Kazuo Noguchi
Makoto Nishio
Investigational New Drugs, 2024, 42 : 136 - 144
[3] Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer
Zhou, Zheng-tao
Zhou, Fu-xiang
Wei, Qing
Zou, Li-yong
Qin, Bin-fang
Peng, Xu-shen
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (04) : 1027 - 1032
[4] Phase II study of cisplatin/etoposide and endostar for extensive-stage small-cell lung cancer
Zheng-tao Zhou
Fu-xiang Zhou
Qing Wei
Li-yong Zou
Bin-fang Qin
Xu-shen Peng
Cancer Chemotherapy and Pharmacology, 2011, 68 : 1027 - 1032
[5] Clinical correlation of extensive-stage small-cell lung cancer genomics
Dowlati, A.
Lipka, M. B.
McColl, K.
Dabir, S.
Behtaj, M.
Kresak, A.
Miron, A.
Yang, M.
Sharma, N.
Fu, P.
Wildey, G.
ANNALS OF ONCOLOGY, 2016, 27 (04) : 642 - 647
[6] Current and future perspectives in extensive-stage small-cell lung cancer
Lim, Jeong Uk
Ryu, Woo Kyung
Park, Nuri
Choi, Juwhan
Lee, Eunyoung
Lee, Sang-Yun
Lim, Jun Hyeok
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
[7] Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer
Li, Lingling
Liu, Tingting
Liu, Qingyan
Mu, Shuai
Tao, Haitao
Yang, Xuhui
Li, Yao
Xiong, Qi
Wang, Lijie
Hu, Yi
FRONTIERS IN PHARMACOLOGY, 2022, 13
[8] Lung Immune Prognostic Index (LIPI): Prognostic predictor for patients with extensive-stage small-cell lung cancer
Majidova, Nargiz
Seyyar, Mustafa
Guren, Ali Kaan
Kocaaslan, Erkam
Kircali, Muhammed Fatih
Sever, Nadiye
Erel, Pinar
Agyol, Yesim
Pacaci, Burak
Tunc, Mustafa Alperen
Bayoglu, Ibrahim Vedat
MARMARA MEDICAL JOURNAL, 2025, 38 (01): : 24 - 28
[9] Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis
Watanabe, Naohiro
Taniguchi, Hiroyuki
Kondoh, Yasuhiro
Kimura, Tomoki
Kataoka, Kensuke
Nishiyama, Osamu
Kondo, Masashi
Hasegawa, Yoshinori
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (02) : 260 - 265
[10] Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects
Saida, Yu
Watanabe, Satoshi
Kikuchi, Toshiaki
ONCOTARGETS AND THERAPY, 2023, 16 : 657 - 671

← 1 2 3 4 5 →